The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1E,4E)-1-(1-(sec-Butyl)-1H-imidazol-2-yl)-5-(5-methylisoxazol-3-yl)penta-1,4-dien-3-one ID: ALA4211719
PubChem CID: 145964798
Max Phase: Preclinical
Molecular Formula: C16H19N3O2
Molecular Weight: 285.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1cc(C)on1
Standard InChI: InChI=1S/C16H19N3O2/c1-4-12(2)19-10-9-17-16(19)8-7-15(20)6-5-14-11-13(3)21-18-14/h5-12H,4H2,1-3H3/b6-5+,8-7+
Standard InChI Key: JFPKKNKUTRYVKH-BSWSSELBSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
13.5654 -18.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0503 -17.3541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7147 -16.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1997 -15.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8641 -15.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8943 -16.5142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4290 -13.7272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1740 -14.5119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3490 -14.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0941 -13.7272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7615 -13.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7615 -12.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9009 -18.7752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7079 -18.9467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7941 -19.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0405 -20.1028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4884 -19.4897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6679 -19.5759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1830 -18.9085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3625 -18.9947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3324 -20.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
3 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
7 11 1 0
11 12 1 0
5 9 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
18 19 1 0
19 20 1 0
18 21 1 0
17 18 1 0
1 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 285.35Molecular Weight (Monoisotopic): 285.1477AlogP: 3.45#Rotatable Bonds: 6Polar Surface Area: 60.92Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.00CX LogP: 3.25CX LogD: 3.23Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: -0.98
References 1. Zhang X, Guo S, Chen C, Perez GR, Zhang C, Patanapongpibul M, Subrahmanyam N, Wang R, Keith J, Chen G, Dong Y, Zhang Q, Zhong Q, Zheng S, Wang G, Chen QH.. (2017) Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies., 137 [PMID:28601720 ] [10.1016/j.ejmech.2017.05.062 ]